Oncology Research and Treatment

Papers
(The median citation count of Oncology Research and Treatment is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic27
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution23
35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin20
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien: Abstracts17
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress), 01.-04. Oktober 2021: Abstracts15
ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway15
The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis14
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study13
Why Do Our Cancer Patients Sleep So Badly? Sleep Disorders in Cancer Patients: A Frequent Symptom with Multiple Causes13
Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors13
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-11
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events11
Current Treatment Approaches to Newly Diagnosed Multiple Myeloma11
Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article11
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma11
Metronomic Chemotherapy for Metastatic Breast Cancer10
Prognostic Value of LRG1 in Breast Cancer: A Retrospective Study10
Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis10
Expression of BCRP/ABCG2 Protein in Invasive Breast Cancer and Response to Neoadjuvant Chemotherapy10
Effectiveness of Supportive-Expressive Group Therapy in Women with Breast Cancer: A Systematic Review and Meta-Analysis10
Targeting HER2 in Biliary Tract Carcinomas: Challenges and Opportunities10
No Impact of the Increased Number of Cardiovascular Risk Factors on Thrombosis and Survival in Polycythemia Vera9
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA9
Antibody-Drug Conjugates for Breast Cancer9
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 13. bis 16. Oktober 2023, Hamburg: Abstracts9
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study8
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-An7
Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action7
Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer7
The Lung Immune Prognostic Index May Predict the Efficacy of Different Treatments in Patients with Advanced NSCLC: A Meta-Analysis7
Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2− Breast Cancer: A Systematic Review and Meta-Analysis6
Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center6
Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein6
Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A6
Recent Advances in Castleman Disease6
Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Systematic Review and Indirect Comparison6
BRAF V600E Mutation in Triple-Negative Breast Cancer: A Case Report and Literature Review6
Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a <b><i>ROS1</i></b> p.L1950F Mutation: Case Report5
Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO5
Patterns of Treatment Failure after Concurrent Chemoradiotherapy or Adjuvant Radiotherapy in Patients with Locally Advanced Cervical Cancer5
Programmed Cell Death Protein 1 Blockade Elicits Ongoing Remission in 2 Cases of Refractory Epstein-Barr Virus-Associated Metastatic Gastric Carcinoma5
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation5
Incidence, Prevalence, and Real-World Treatment Patterns in Chronic Myeloid Leukemia: Results from a Population-Representative German Claims Data Analysis5
Development of Skin Rash Predicts Outcome of Anti-PD-1- and Anti-CTLA4-Based Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer or Squamous Cell Carcinoma of the Head and Neck: A Single5
The Impact of Platinum-Containing Chemotherapies in Advanced Triple-Negative Breast Cancer: Meta-Analytical Approach to Evaluating Its Efficacy and Safety5
Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report5
Shared Decision-Making in Oncology: Preferences in Older versus Younger Patients of an Oncology Clinic – A Conjoint Analysis4
Contralateral Axillary Lymph Node Metastasis in a Patient with Relapsed Breast Cancer: Locoregional Event or Distant Metastasis Disease?4
Comparative Analysis of Postoperative Complications after Cytoreductive Surgery and HIPEC in Gastric Cancer4
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review4
Preoperative Conization May Have a Positive Impact on Survival in Early-Stage Cervical Cancer: A Propensity-Matched Study4
Career and Professional Development for Young Oncologists4
Five-Fraction Stereotactic Radiotherapy for Brain Metastases: A Single-Institution Experience on Different Dose Schedules4
Family Formation and Socio-Economic Status among 35-Year-Old Men Who Have Survived Cancer in Childhood and Early Adulthood: A Register-Based Cohort Study4
Abdominal Wall Reconstruction Using Omental Flap with Mesh Repair following Resection of Aggressive Abdominal Wall Neoplasms4
Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis4
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland3
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation3
Adjuvant Therapy in Resected Nonmetastatic Stage II–IV Gallbladder Cancer: A Generalized Propensity Score Analysis3
Recursive Partitioning Analysis of Systemic Therapy after Radiotherapy in Patients with Brain Metastases3
Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors3
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer3
Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre Experience3
The Study of Cerebral Blood Flow Variations during Brain Metastases Radiotherapy3
Discoidin Domain Receptor 2: A New Target in Cancer3
Medical Care and Survival of Soft-Tissue and Bone Sarcoma Patients: Results and Methodological Aspects of a German Subnational Cohort Study Based on Administrative Healthcare Data3
The Future Role of PET Imaging in Metastatic Breast Cancer3
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma3
Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approac3
The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial3
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis3
Regulation of miR-126 and miR-122 Expression and Response of Imatinib Treatment on Its Expression in Chronic Myeloid Leukemia Patients3
Supportive Care Needs and the Impact of Loss of Functioning and Symptom Burden on the Quality of Life in Patients with Advanced Colorectal Cancer3
Enhanced LINC01061 Levels as a Serum Biomarker in Gastric Cancer and Promotion of Malignant Transformation3
Value of HSP90α in Lung Cancer Diagnosis and Recurrence Prediction: A Cohort Study3
Vorwort des DGHO-Vorstandes3
Effect of Postoperative Radiotherapy in Thymoma Patients: A SEER-Based Study2
Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort2
Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study2
Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients2
The Importance of a Detailed Geriatric Functional Assessment of Older Patients with Cancer2
Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study2
Risk and Prognosis of Subsequent Primary Gastric Cancer2
Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates2
A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong2
Inflammatory Myofibroblastic Tumor in the Thyroid Gland: A Retrospective Case Series Study and Literature Review2
The Poor Prognosis of Patients with Stage III Gastric Cancer after D2 Dissection Is Mainly due to Lymphatic Metastasis, Especially the Metastasis of No.12a LN: A Nested Case-Control Study2
Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient Rehabilitation2
Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 Patients2
Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?2
Evidence Mapping of Proton Therapy, Heavy Ion Therapy, and Helical Tomotherapy for Gastric Cancer2
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients2
Administration of Valproic Acid Improves the Survival of Patients with Glioma Treated with Postoperative Radiotherapy2
Efficacy of Lutetium-Peptide Receptor Radionuclide Therapy in Inducing Prolonged Tumour Regression in Small-Bowel Neuroendocrine Tumours: A Case of Favourable Response to Retreatment after Initial Obj2
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer2
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study2
MLH1 Exon 12 Gene Deletion Leading to Lynch Syndrome: A Case Report2
Treatment of Metastatic Colorectal Carcinoma with Bevacizumab in First-Line and beyond First Progression: The KORALLE Non-Interventional Cohort Study2
Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral Center2
Efficacy and Safety of PD-1 Immune Checkpoint Inhibitors in Locally Advanced and Advanced Non-Small-Cell Lung Cancer Patients with Chronic Infection2
Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort2
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis2
Prognosis Comparisons of Laparoscopy versus Open Surgery for Rectal Cancer Patients after Preoperative Chemoradiotherapy: A Meta-Analysis2
PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation2
Stereotactic Radiotherapy for Adrenal Metastases: A Multi-Institutional Review of Patient Characteristics and Outcomes – Turkish Society for Radiation Oncology SBRT Group Study (Trod SBRT 10-004)2
Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis1
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice1
Durable Responses to Chemotherapy in Patients with Metastatic Soft-Tissue Sarcoma1
Klinische Studien in der Hämatologie und Onkologie1
Front & Back Matter1
Perspectives for Cancer Care and Research in Central and Eastern Europe1
New Opportunities in Advanced Breast Cancer1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres1
Seizures and Neuropsychiatric Toxicity in Patients with Non-Metastatic CRPC Treated with New Antiandrogens: Systematic Review and Meta-Analysis1
Management of Aortoesophageal Fistula in a Palliative Patient with Non-Small-Cell Lung Cancer: A Case Report1
A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma1
Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center Experience1
Curative, Organ-Sparing, Multimodal, Perioperative Treatment of a Young Patient with a Rectoanal Inflammatory Myofibroblastic Tumor1
Preliminary Clinical Validation of a Filtration-Based CTC Assay for Tumor Burden and HER2 Status Monitoring in Metastatic Breast Cancer1
Onkologie und Ökonomie – wie frei sind wir wirklich in der Behandlung von Patient*innen?1
A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model1
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report1
Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience1
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial1
Bone Infarct-Associated Osteosarcoma: Epidemiologic and Survival Trends1
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial1
Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional Europe1
Low Expression of miR-663a Indicates Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion in Breast Cancer1
Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 751
Oncologic Rehabilitation in the COVID-19 Pandemic: The Situation in Clinics1
Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study1
How an Oncologist’s Intuition Compares to a Geriatric Assessment1
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Pla1
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with Cancer1
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System Lymphoma1
Curative Polyendocrine Therapy in a 21-year-Old Patient with Endometrial Carcinoma: Case Report and Review of the Literature1
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review1
An Unusual Case of Hypopituitarism as an Adverse Effect of Vandetanib and Remission of Breast Metastases in a Patient with Medullary Thyroid Cancer1
Impact of Geriatric Assessment on the Tolerability of Combination Chemotherapy in Older Patients with Advanced Cancer: A Matched-Pair Analysis1
Effectiveness of Long-Term Treatment of Multiple Myeloma in Regular Care: Comparison of a Longitudinal and a Cross-Sectional Analysis Approach1
ASCO Annual Meeting 2021: Neues zu PARP-, PD-1- und CDK4/6-Inhibitoren zur Therapie des Mammakarzinoms0
Society Bulletins0
PharmaNews0
Front & Back Matter0
PharmaNews0
Luspatercept bei Niedrigrisiko-MDS: MEDALIST-Studie zeigt Mehrfachansprechen0
A Taxonomy for Psycho-Oncological Intervention Techniques in an Acute Care Hospital in Germany0
Society Bulletins0
A Randomized, Controlled Pilot Study to Evaluate the Immediate Effect of Targeted Exercise Therapy on Cancer-Related Fatigue in Cancer Survivors: The FatiGO Study0
Society Bulletins0
PharmaNews0
Society Bulletins0
Onkopedia-Leitlinie empfiehlt Gilteritinib bei R/R FLT3+ AML0
PharmaNews0
Front & Back Matter0
Society Bulletins0
PharmaNews0
Durvalumab-Immuntherapie: Dauer beeinflusste Erfolg0
Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany0
Prelims0
PharmaNews0
Highlights of translational and molecular research presented at the European Society for Medical Oncology Annual Meeting 20230
OnkoImmun 190
Erratum0
Das inoperable NSCLC im Stadium III im Dialog0
PharmaNews0
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas0
Vorspann0
Society Bulletins0
PharmaNews0
Front & Back Matter0
Front & Back Matter0
PharmaNews0
Society Bulletins0
Front & Back Matter0
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie0
Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?0
Society Bulletins0
PharmaNews0
Cabozantinib plus Nivolumab: Neuer RCC-Erstlinienstandard?0
Society Bulletins0
Zulassungserweiterung Yescarta beim r/r FL0
PharmaNews0
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center0
Therapiemanagement nach einer CAR-T-Zell-Therapie0
Nintedanib und Docetaxel beim Adenokarzinom der Lunge0
Front & Back Matter0
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group0
Society Bulletins0
Contents Vol. 46, 20230
Front & Back Matter0
36. Deutscher Krebskongress. Fortschritt gemeinsam gestalten, 21.–24. Februar 2024, Berlin: ABSTRACTS0
PharmaNews0
PharmaNews0
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study0
Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 20220
CLL: Daten bestätigen Nutzen von Venetoclax-Kombinationstherapien0
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review0
PharmaNews0
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study0
Society Bulletins0
Front & Back Matter0
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom0
PharmaNews0
Society Bulletins0
Society Bulletins0
Prelims0
Front & Back Matter0
Acknowledgement to Reviewers0
Maintaining an Adult Hematology/Oncology Service at a Tertiary Care Center during the SARS-CoV-2 Pandemic: An Eight-Week-Experience with a Newly Implemented Procedural Plan0
Front & Back Matter0
Post-Chemotherapy Rebound Thymic Hyperplasia Mimicking Relapse in Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report0
Radiofrequency Thermoablation and Hypofractionated Radiotherapy Combined Treatment for Bone Metastases: A Retrospective Study0
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%0
OnkoImmun 140
Inrebic®: Neue Behandlungsoption bei Myelofibrose0
EC/GEJC: Adjuvante Immuntherapie ergänzt kurativen Behandlungsansatz0
PharmaNews0
Vorwort0
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols0
A Systematic Review for Evaluation of Specialized Programs for Addressing Young Women with Breast Cancer Problems0
Nivolumab plus Ipilimumab beim metastasierten Melanom0
Contents Vol. 44, 20210
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells0
AGGRESSIVE B CELL LYMPHOMA WITH METASTATIC SPINAL CORD COMPRESSION: TREAT THE PATIENT, NOT THE DISEASE.0
Front & Back Matter0
Multiples Myelom: Langzeitergebnisse der MAIA-Studie0
Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma0
Atezolizumab beim operablen NSCLC0
Chronic Cutaneous Disorders Are Associated with a More Favorable Disease Presentation and Outcome in Patients with Hodgkin Lymphoma0
KRAS – ein neuer prädiktiver Biomarker am Horizont0
Society Bulletins0
CTCL-Therapie mit Mogamulizumab0
Melflufen: Therapieoptionen beim Multiplen Myelom0
Society Bulletins0
PharmaNews0
OnkoImmun 170
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany0
Polypharmazie - Wechselwirkungen der BTKi0
Front & Back Matter0
Front & Back Matter0
uGI: Biomaker-Cut-Offs in der Immunonkologie0
Front & Back Matter0
Management of Patients Undergoing CAR-T Cell Therapy in Germany0
Society Bulletins0
Oncology in Europe0
Front & Back Matter0
PharmaNews0
Multiple Myeloma: The Success Story Continues0
0.035579919815063